Guanyu Chen

Prof. Dr. Guanyu Chen

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2026 in Immunity & Inflammation
Verified
Journal Article
Open access
PDF file
ZHZhenglin He
Zhenglin He
HHHanming Hao
Hanming Hao
BCBaoer Chen
Baoer Chen
XLXuechao Li
Xuechao Li
DMDezhi Mao
Dezhi Mao
GCGuanyu Chen
Guanyu Chen
Osteoarthritis (OA), the leading global cause of joint-related disability, is increasingly viewed as an immune-mediated disorder rather than mere mechanical wear-and-tear. Yet how resident and infiltrating immune cells, inflammatory mediators and dysregulated signaling networks act in concert to perpetuate synovitis, erode cartilage and remodel subchondral bone remains a central enigma. This review dissects the cellular and molecular choreography underlying OA pathology. We detail how macrophages, dendritic cells (DCs), neutrophils, mast cells (MCs), natural killer cells (NK cells), T cells, and B cells orchestrate destructive immune-bone crosstalk within the joint microenvironment. Key inflammatory mediators such as tumor necrosis factor-alpha (TNF-α), transforming growth factor-beta (TGF-β), interleukins (e.g., interleukin (IL)-1β, IL-6), and chemokines sustain this inflammatory loop, further perpetuating inflammation and cartilage damage. Dysregulated signaling pathways, such as nuclear factor-kappa B (NF-κB) and Wingless-type (Wnt)/β-catenin, are coordinated with inflammatory mediators, thereby contributing to the pathophysiology of OA. Beyond mechanism, we critically evaluate cutting-edge therapeutic strategies targeting these osteoimmunological and molecular mechanisms, such as immunomodulatory therapy, mesenchymal stem cell (MSC) therapy and small-molecule pathway inhibitors. Preclinical successes underscore the feasibility of targeting immune-signaling axes to halt or reverse OA progression. By elucidating these mechanisms and therapeutic targets, this review aims to advance the development of disease-modifying therapies and improve outcomes for OA patients.

23 July 2025 in International Dental Journal
Verified
Journal Article
Open access
LYLin Yang
Lin Yang
GCGuanyu Chen
Guanyu Chen
Deep learning methods have been proven to be effective in detecting dental caries in visible light images. However, existing research involves inadequate categories and mainly focuses on local lesion areas. This study aims to use advanced deep learning models to achieve caries detection based on tooth instances (where all teeth in images are detected) and fine-grained classification according to the International Caries Detection and Assessment System (ICDAS). To address the potential instability under complex scenarios, we propose 2 correction methods that incorporate background knowledge. A total of 1200 selected high-quality intraoral images were expanded to 8,754 images using data augmentation techniques, and each tooth inside was annotated. Three advanced models, YOLO-v8, YOLO-v9, and YOLO-NAS, were trained and tested on the dataset. In the stage of postprocessing, predicted categories were corrected with a weighted average of scores, and confidence scores were adaptively adjusted based on the spatial relationships of teeth. The proposed methods improved the mean Average Precision (mAP) scores by 4.7% (p < .01/Mann-Whitney-U-test), 2.8% (p < .01), and 4.4% (p < .01) across the 3 models, with the highest score of 72.9% on YOLO-v8. Precision and recall increased by 3.8% and 5.6%, respectively, while FPS decreased from 83.1 to 78.1. Especially improved the scores for moderate caries and demonstrated greater robustness. The primary objectives were achieved, and the 2 proposed correction methods bring an effective improvement to the existing algorithm framework. It's expected to promote the application of artificial intelligence and inspire further research. This research is of clinical value due to its functional innovation: the finer classification should assist dentists formulate personalized treatment strategies. Focusing on the detailed evaluation of each tooth should help deliver better and personalised clinical care.

2 December 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XLXuechao Li
Xuechao Li
YRYifei Ren
Yifei Ren
HHHanming Hao
Hanming Hao
YJYi Jin
Yi Jin
BCBaoer Chen
Baoer Chen
ZHZhenglin He
Zhenglin He
Long non-coding RNAs (lncRNAs) are emerging as master regulators of the lung cancer tumor microenvironment (TME), where they reprogram immune cell functions, cytokine networks, and checkpoint signaling to create an immunosuppressive and therapy-resistant landscape. This review offers a comprehensive analysis of how lncRNAs mediate the interplay between tumor cells and immune components, underscoring their context-dependent roles as both oncogenic drivers and microenvironmental suppressors. It also highlights their clinical utility as liquid-biopsy biomarkers and their central role in conferring resistance to chemo- and radio-therapy. This review synthesizes current knowledge on the interplay between lncRNAs and the TME, highlighting the targeting of specific lncRNAs as a novel therapeutic strategy for precision lung cancer therapy.

26 January 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XLXuechao Li
Xuechao Li
YRYifei Ren
Yifei Ren
SPShenghua Pei
Shenghua Pei
KZKai Zhao
Kai Zhao
GCGuanyu Chen
Guanyu Chen
ZHZhenglin He
Zhenglin He
Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive malignancy with a persistently high mortality rate, largely attributable to therapy resistance and tumor recurrence. This review comprehensively explores the critical interplay between epigenetic dysregulation and the tumor microenvironment (TME) in driving OSCC progression. We detail how key epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs (ncRNAs), intrinsically transform cancer cells and actively orchestrate pro-tumorigenic TME. These alterations substantially contribute to resistance against conventional therapies. Furthermore, we discuss the therapeutic potential of targeting these pathways using epigenetic drugs (epi-drugs), such as DNA methyltransferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors, as well as engineered extracellular vesicles (EVs). The primary objective of this review is to synthesize current knowledge on the epigenetic-TME axis, thereby providing a mechanistic foundation for developing novel therapeutic strategies. We emphasize that rational combinations of epigenetic-targeting agents with conventional treatments or immunotherapy hold significant promise for overcoming drug resistance and improving clinical outcomes in OSCC patients.

21 November 2025 in Cell Biology International
Verified
Journal Article
Closed access
MLMeng Liu
Meng Liu
XWXiaotong Wang
Xiaotong Wang
HZHaowen Zhou
Haowen Zhou
XYXiaoqian Yang
Xiaoqian Yang
GCGuanyu Chen
Guanyu Chen
ASAimei Song
Aimei Song

26 January 2026 in World Journal of Stem Cells
Verified
Journal Article
Open access
GCGuan-Yu Chen
Guan-Yu Chen
JKJia-Bing Kang
Jia-Bing Kang
YWYu-Kai Wang
Yu-Kai Wang
GCGuanyu Chen
Guanyu Chen
A recently published prospective study marks a breakthrough for congenital olfactory disorders in children. The study provides the first long-term, three-year follow-up data, robustly demonstrating the durable efficacy and safety of autologous nasal epithelial stem cell transplantation. This work reveals immense therapeutic potential for a condition traditionally considered untreatable. However, this milestone achievement also presents new challenges. To translate this pioneering therapy from a single-center success to a global standard, multicenter, controlled clinical trials must be initiated immediately. Only through rigorous validation can we ensure its widespread adoption and ultimately bring hope to millions of children worldwide.